Kelly Little Arryo, Hale AdvisorsKELLY LITTLE-ARROYO
Global Multichannel Strategy Leader


Kelly is our Global Multi-Channel Strategy Leader here at Hale Advisors. She is an experienced multi-channel marketing strategy professional with expertise in implementing global programs across multiple therapeutic areas for healthcare professionals, patients and consumers. She is an expert in strategic planning, governance, marketing and execution of initiatives to drive acquisition, retention and loyalty, while delivering an optimal customer experience based on behavior and CRM. Kelly has more than 25 years in the pharmaceutical industry with management roles in marketing strategy, digital marketing, consulting and sales among top companies including Novartis, Pfizer, Merck, Janssen and Bayer. 


Kelly holds a B.S. in Advertising from the Newhouse School at Syracuse University and an M.B.A. in Marketing from Columbia Business School. She is active in the volunteer space and served as a board member for Skaneteles Education Foundation for over two years and currently volunteers at fundraising and events for the Auburn Public Theater.


Kelly relocated to Skaneateles, NY a few years ago from New Jersey, where she and her husband Manuel raise their three children, August, Ella and Magnus in a bucolic Finger Lakes community. 


SXSW 2019: Business Value of Design, Curiosity & Audio Branding

My second time visiting South by Southwest (SXSW) was once again an incredible experience. There is no energy like that of Austin during this annual event. The streets were swarming with people eager to learn and network. The convention center was full of trade show vendors from industries ranging from...

mHealth: Hope or hype? What should Pharma expect?

What is mHealth? It’s a group of technology offerings that include wearables, apps, and medical devices that connect to your phone or any mobile or wireless device that enhances personal health. I’m sure most of you reading this have had some experience with wearables. Perhaps you use them to tell...

Is pharma missing its social media moment?

Here’s a snippet of a conversation I had about seven years ago with a particularly nervous promotional review team that was considering the value of developing a presence on Twitter: “If we create a profile and all these people follow us, and all these people post adverse events, how will...

Athletes & Dietary Supplements: Where’s the Regulation?

It’s no question that steroid use and doping is a major problem in professional and college sports. In the 2018 preseason the NFL had 14 performance enhancing drugs (PED) related suspensions. The MLB had four such suspensions the most prominent being 8x MLB All-Star Robinson Cano. However, none of these...